0.2% ropivacaine
0.2% ropivacaine is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
PENG Block and Delirium After Hip Arthroplasty
Erector Spinae Plane Block for Cervical Spine Surgery
Transverse Abdominis Plane (TAP) Block After Cesarean Delivery
Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty
Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery
Clinical Trials (8)
PENG Block and Delirium After Hip Arthroplasty
Erector Spinae Plane Block for Cervical Spine Surgery
Transverse Abdominis Plane (TAP) Block After Cesarean Delivery
Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty
Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery
Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain
Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections
Paravertebral Catheter for Lung Transplant
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8